Neut-X can be successfully used as diagnostic and prognostic tool in MDS.

[1]  A. A. van de Loosdrecht,et al.  Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes , 2018, Pathobiology.

[2]  L. Saft,et al.  Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells. , 2018, Leukemia research.

[3]  G. Ossenkoppele,et al.  Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias. , 2016, European journal of cancer.

[4]  G. Garcia-Manero.  CME Information: Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification and management , 2014 .

[5]  U. Germing,et al.  Myelodysplastic syndromes: diagnosis, prognosis, and treatment. , 2013, Deutsches Arzteblatt international.

[6]  M. Cazzola,et al.  Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. , 2013, Blood.

[7]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[8]  C. Pascutto,et al.  Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study , 2012, Haematologica.

[9]  U. Germing,et al.  Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes. , 2012, Leukemia research.

[10]  D. Costa,et al.  The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. , 2012, Leukemia research.

[11]  Raviv Raich,et al.  Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profiling , 2011, Cytometry. Part B, Clinical cytometry.

[12]  Christina Hoffmann,et al.  Granularity Index of the SYSMEX XE-5000 hematology analyzer as a replacement for manual microscopy of toxic granulation neutrophils in patients with inflammatory diseases , 2011, Clinical chemistry and laboratory medicine.

[13]  M. Uranga,et al.  The utility of the Sysmex XE‐2100 analyzer’s NEUT‐X and NEUT‐Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes , 2010, International journal of laboratory hematology.

[14]  H. Deeg,et al.  Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. , 2003, Blood.

[15]  A. Öst,et al.  Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. , 1989, Leukemia research.